Kya Odom, a Gen Z from Columbus, Ohio, opted for a facial fat transfer after losing significant weight. This procedure, similar to a BBL, uses liposuctioned fat to re-inflate patients' cheeks. The trend is on the rise due to the popularity of weight loss injectables like Ozempic, Wegovy, and Mounjaro, as many individuals experience facial volume loss after rapid weight loss.
Kya Odom underwent a facial fat transfer after losing significant weight. It's a growing trend amongst those who have lost weight recently as injectibles like Ozempic , Wegovy and Mounjaro have taken off.So, to re-plump her mug after shrinking from 155 to 125 pounds, the newly svelte Gen Z from Columbus, Ohio opted for a facial fat transfer .
But rather than repack on the pounds, guys and gals are booking appointments to plump up with a doctor’s syringe. To repair the drooping damage, Madnani typically harvests donor fat from the abdomen or flanks. He then inserts between five to 20 cubic centimeters, or CCs, into the face, depending on the level of volume loss and the patient’s desired look.
“I can leave the house more quickly as it takes much less for me to be presentable,” continued the New Yorker, who recently went from 215 to 125 pounds with bariatric surgery.
Ozempic Wegovy Mounjaro Facial Fat Transfer Weight Loss Cosmetic Surgery
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ozempic and Similar Drugs May Raise Risk of Rare Vision Loss DisorderEuropean health officials are investigating a potential link between Ozempic and other GLP-1 medications and a rare but serious eye disorder called NAION.
Read more »
Ozempic Linked to Potential Vision Loss, Danish Agency SaysThe Danish Medicines Agency is investigating a potential link between the popular diabetes drug Ozempic and vision loss.
Read more »
Ozempic Linked to Increased Cases of Vision LossThe Danish Medicines Agency has reported an increase in cases of non-arteritic anterior ischemic optic neuropathy (NAION), a condition causing vision loss, potentially linked to Ozempic, a popular weight-loss drug. While Novo Nordisk maintains the drug's safety profile, the concern highlights the need for continued monitoring of potential side effects associated with GLP-1 medications.
Read more »
Ozempic Linked to Possible Vision Loss, Danish Agency SaysThe Danish Medicines Agency is investigating a possible link between Ozempic and a rare form of vision loss called NAION (non-arteritic anterior ischemic optic neuropathy). While the company maintains the drug's safety, the agency has reported an increase in NAION cases since Ozempic's introduction in Denmark.
Read more »
Elon Musk Pushes for Federally Funded Ozempic and Less Government SpendingMusk's plan to cut $2 trillion in federal spending could clash with his proposal to subsidize a drug costing up to $1,000 a month.
Read more »
‘The View’ hosts side with Musk over RFK Jr. on Ozempic: ‘Elon’s right on this’‘The View’ hosts say Elon Musk's stance on GLP inhibitors is 'right'
Read more »